Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)

SHE:002581 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	-	151.91	183.8	187.8	284.15
Cash & Short-Term Investments	428.85	151.91	183.8	187.8	284.15
Cash Growth	182.30%	-17.35%	-2.13%	-33.91%	-74.65%
Accounts Receivable	-	172.62	179.72	272.96	353.77
Other Receivables	-	78.87	18.36	13.49	16.75
Receivables	-	251.49	198.09	286.45	370.52
Inventory	-	85.31	80.04	64.33	70.87
Other Current Assets	-	7.99	56.43	29.88	40.62
Total Current Assets	-	496.71	518.36	568.45	766.16
Property, Plant & Equipment	-	357.84	705.47	713.76	684.72
Long-Term Investments	-	1,355	1,503	1,223	751.21
Other Intangible Assets	-	108.29	126.32	134.29	144.55
Long-Term Deferred Tax Assets	-	6.12	11.84	25.28	25.14
Long-Term Deferred Charges	-	1.41	5.2	7.78	7.72
Other Long-Term Assets	-	12.26	0.49	83.36	65.46
Total Assets	-	2,337	2,870	2,756	2,445
Accounts Payable	-	73.69	43.64	42.13	14.46
Accrued Expenses	-	16.64	19.32	31.01	32.34
Short-Term Debt	-	13.84	150.42	151.54	118.5
Current Portion of Leases	-	-	13.46	15.83	20.82
Current Income Taxes Payable	-	0.95	1.2	0.44	0.65
Current Unearned Revenue	-	3.59	26.86	3.43	1.21
Other Current Liabilities	-	24.9	109.38	14.17	18.9
Total Current Liabilities	-	133.61	364.28	258.54	206.87
Long-Term Leases	-	0.71	1.47	9.8	27.77
Long-Term Unearned Revenue	-	5.49	6.71	9.74	10.96
Long-Term Deferred Tax Liabilities	-	7.51	7.68	8.68	8.74
Other Long-Term Liabilities	-	16.09	9.67	-	-
Total Liabilities	-	163.41	389.82	286.76	254.33
Common Stock	-	229.15	229.15	229.15	229.15
Additional Paid-In Capital	-	873.93	858.5	858.29	858.29
Retained Earnings	-	965.39	1,298	1,301	1,030
Total Common Equity	2,090	2,068	2,385	2,388	2,117
Minority Interest	-	105.26	94.94	81.11	73.43
Shareholders' Equity	2,205	2,174	2,480	2,469	2,191
Total Liabilities & Equity	-	2,337	2,870	2,756	2,445
Total Debt	0.21	14.55	165.35	177.16	167.09
Net Cash (Debt)	428.64	137.36	18.45	10.64	117.06
Net Cash Growth	212.04%	644.38%	73.50%	-90.91%	-43.55%
Net Cash Per Share	0.65	0.21	0.03	0.02	0.18
Filing Date Shares Outstanding	662.85	659.74	659.74	659.74	659.74
Total Common Shares Outstanding	662.85	659.74	659.74	659.74	659.74
Working Capital	-	363.1	154.08	309.91	559.3
Book Value Per Share	3.18	3.14	3.62	3.62	3.21
Tangible Book Value	1,988	1,960	2,259	2,254	1,973
Tangible Book Value Per Share	3.02	2.97	3.42	3.42	2.99
Buildings	-	486.08	639.62	612.92	426.35
Machinery	-	432.25	413.16	424.47	345.34
Construction In Progress	-	22.17	91.43	64.86	353.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.